Valuation (67%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -71.62 | -10.78 |
PEG Ratio (TTM) | 0.55 | -0.35 |
P/S Ratio (TTM) | 1.06 | 1.13 |
P/B Ratio (TTM) | 0.97 | 1.71 |
P/FCF Ratio (TTM) | 70.23 | 29.94 |
Price to 5YR AVG Earnings Ratio | 8.08 | 23.35 |
Price to 5YR AVG FCF Ratio | 6.30 | 7.82 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.04% | 3.71% |
ROE (TTM) | -1.33% | 8.66% |
Net Profit Margin (TTM) | -1.53% | 4.82% |
ROIC 5YR AVG | 26.47% | 18.16% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -14.08% | 237.42% | 115.57% |
Revenue | -3.67% | 45.09% | 18.81% |
Net Income | -13.10% | 297.98% | 150.50% |
Cash Flow | 243.58% | 405.50% | 220.49% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.82 | 2.56 |
Quick Ratio (TTM) | 1.17 | 1.83 |
D/E Ratio (TTM) | 0.07 | 0.98 |
Interest Coverage (TTM) | -4.26 | 10.33 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 3.39 | 3.06 |
LTL to 5YR AVG FCF | 0.21 | 7.86 |
Shares Outstanding Growth 5YR AVG | 5.14% | 2.27% |